An underground economy for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on communication apps, based on new investigations.
Investigational Drug Gaining Traction Via Social Media
The experimental drug, which is still in research studies, is being advertised by online personalities for its alleged weight-reducing effects. Followers are encouraged to message these profiles privately for supplier links, while also receiving promotional offers.
Thriving Trade on Messaging Platforms
Additionally, a flourishing trade exists on messaging services, where groups with numerous of members share “before and after” images, administration instructions and assertions of next-day British shipping. Sellers market the substance there before redirecting customers to other platforms for transactions.
Understanding The Experimental Drug
Retatrutide is an investigational injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Preliminary studies suggest it could help patients reduce up to a quarter of their body weight. Referred to as the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Healthcare Professionals Express Worries
Nevertheless, doctors and chemists have warned that the distribution of what is still an unlicensed drug in the UK is worrisome and could lead to users injecting products of unknown origin.
Some experts stated the popularity for retatrutide could be linked to the increasing cost of approved slimming products such as Mounjaro.
Legal Position and Enforcement
Marketing the unapproved drug on TikTok or messaging apps is prohibited in the UK, as it is an unlicensed drug that cannot be marketed or supplied for personal consumption under the Human Medicines Regulations 2012.
Several content creators attempt to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still breach pharmaceutical, advertising, and consumer regulations, risking penalties, legal action or imprisonment.
Platform Reaction and Material Elimination
Based on TikTok, the service has removed violative material and prohibited associated keywords and search suggestions. The organization said it was committed to keeping the platform secure and allocating resources in strengthening enforcement strategies.
Online Marketplace Activities
Investigations also found communities with up to 9,000 members marketing the experimental drug using Telegram's integrated discovery tool, which functions like a online catalog. Entering “retatrutide” immediately brings up groups with thousands of users, populated with images of weight loss, glowing testimonials and step-by-step instructions for mixing or administering at home.
After moments of joining one group, a vendor posted WhatsApp details, where the majority of purchases take place. The vendor provided an instruction manual and guaranteed delivery within two days. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a photo of a alleged laboratory certificate. None asked about weight, health issues or past usage.
Product Information and Costs
Inside these communities, messages show dark colored packages with postal service labels, stating to include fresh supplies. One message stated: “It took eight of us to load them this morning.”
Customers can select between powder vials, prepared at residence with sterile water, or pre-filled pens usually sold at £160 for 20 milligrams. When questioned how long a pen should be used, sellers give conflicting answers varying between a few weeks to “depends on your body”.
Platform Moderation and Security Actions
A spokesperson for Telegram said it actively monitored dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.
Medical Expert Warnings
“Individuals are injecting materials they cannot confirm. Although the research behind this drug is sound, these online products may not include what they advertise,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to current price rises for approved weight-loss medications such as Mounjaro. “With costs increasing, patients are using online platforms. But counterfeit treatments are extremely risky. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she said.
Her team has already encountered individuals injured by personal administration from unconfirmed sources. “We understand the frustration, but buying from messaging apps or WhatsApp is taking chances with your well-being,” said Wyllie. “These materials could be contaminated or incorrectly dosed.”
Manufacturer Position
A representative from the pharmaceutical company stated the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can market [it] for personal consumption,” they said, adding that any item “falsely representing itself as a company investigational substance not yet authorized … may subject users to possibly significant health risks”.
